Forte Healthcare Ltd has taken over the distribution of Locatim, the long-established and trusted product used to combat calf diarrhoea, in the UK.
The product, manufactured by the company Biokema, is an orally administered medicinal product for calves containing specific immunoglobulins and is indicated for the reduction of mortality caused by enterotoxicosis associated with E. coli F5 (K99).
Locatim is manufactured from the colostrum of high health status cows hyperimmunised against Rotavirus, Coronavirus and E. coli. The concentration of specific antibodies against Enterotoxigenic E. coli F5 (K99) in the product is guaranteed.
Locatim is designed to work alongside the dam’s colostrum, enhancing protection against gastro-intestinal infection, helping to sustain calf health in the critical neo-natal period.
The single 60 ml oral dose provides specific antibodies which initially act locally at the gut mucosa and then systemically after absorption into the general circulation. For optimal effect, Locatim should be given within four hours of birth, but can be used up to 12 hours post-natally.
Locatim is not designed to replace anti-scour vaccination programmes, but rather to act as an extremely useful adjunct in cases where the response to vaccines has been less than ideal. This can be due to poor colostrum quality, high environmental pathogen challenge or poor colostrum intake in calves after dystocia.
Locatim is also extremely useful in managing outbreaks of scour in unvaccinated herds by protecting those calves born before a new vaccination programme can take effect.
Dr John Henderson, MRCVS, large animal product manager at Forte Healthcare, says: “We are delighted to welcome Locatim to our strong veterinary portfolio and we look forward to working with such an established and effective product from a well-recognised manufacturer – Biokema”.
Locatim is available from all UK veterinary wholesalers, and for more information please contact your Forte Territory Manager or contact Forte Healthcare.
